Research ArticleAnkylosing Spondylitis
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort
Monika Hebeisen, Regula Neuenschwander, Almut Scherer, Pascale Exer, Ulrich Weber, Giorgio Tamborrini, Raphael Micheroli, Lukas M. Wildi, Pascal Zufferey, Michael J. Nissen, Peter M. Villiger, Jürg Bernhard, Axel Finckh, Irene E. van der Horst-Bruinsma, Joachim Sieper, Robert Landewé, Désirée van der Heijde, Adrian Ciurea and on behalf of the rheumatologists of the Swiss Clinical Quality Management Program
The Journal of Rheumatology April 2018, 45 (4) 506-512; DOI: https://doi.org/10.3899/jrheum.170166
Monika Hebeisen
From the Swiss Clinical Quality Management Foundation; Department of Rheumatology, Zurich University Hospital, Zurich; Praxis Rheuma-Basel, Basel,
Switzerland; King Christian 10th Hospital for Rheumatic Diseases, Gråsten; Institute of Regional Health Research, University of Southern Denmark, Odense,
Denmark; Ultrasound Center Rheumatology, Basel; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne; Department of Rheumatology, University Hospital, Geneva; Department of Rheumatology and Clinical Immunology, Inselspital, Bern; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn,
Switzerland; Department of Rheumatology, VU University Medical Center, Amsterdam,
the Netherlands; Department of Gastroenterology, Infectiology and Rheumatology, Charité Universitätsmedizin, Berlin,
Germany; Department of Clinical Immunology and Rheumatology, University of Amsterdam; Department of Rheumatology, Zuyderland Hospital, Heerlen; Department of Rheumatology, Leiden University Medical Center, Leiden,
the Netherlands.
Regula Neuenschwander
Almut Scherer
Pascale Exer
Ulrich Weber
Giorgio Tamborrini
Raphael Micheroli
Lukas M. Wildi
Pascal Zufferey
Michael J. Nissen
Peter M. Villiger
Jürg Bernhard
Axel Finckh
Irene E. van der Horst-Bruinsma
Joachim Sieper
Robert Landewé
Désirée van der Heijde
Adrian Ciurea
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 45, Issue 4
1 Apr 2018
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort
Monika Hebeisen, Regula Neuenschwander, Almut Scherer, Pascale Exer, Ulrich Weber, Giorgio Tamborrini, Raphael Micheroli, Lukas M. Wildi, Pascal Zufferey, Michael J. Nissen, Peter M. Villiger, Jürg Bernhard, Axel Finckh, Irene E. van der Horst-Bruinsma, Joachim Sieper, Robert Landewé, Désirée van der Heijde, Adrian Ciurea, on behalf of the rheumatologists of the Swiss Clinical Quality Management Program
The Journal of Rheumatology Apr 2018, 45 (4) 506-512; DOI: 10.3899/jrheum.170166
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort
Monika Hebeisen, Regula Neuenschwander, Almut Scherer, Pascale Exer, Ulrich Weber, Giorgio Tamborrini, Raphael Micheroli, Lukas M. Wildi, Pascal Zufferey, Michael J. Nissen, Peter M. Villiger, Jürg Bernhard, Axel Finckh, Irene E. van der Horst-Bruinsma, Joachim Sieper, Robert Landewé, Désirée van der Heijde, Adrian Ciurea, on behalf of the rheumatologists of the Swiss Clinical Quality Management Program
The Journal of Rheumatology Apr 2018, 45 (4) 506-512; DOI: 10.3899/jrheum.170166